Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001062993-24-021301
Filing Date
2024-12-31
Accepted
2024-12-30 19:35:10
Documents
80
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 20-F form20f.htm   iXBRL 20-F 1827445
2 EXHIBIT 2.2 exhibit2-2.htm EX-2.2 7712
3 EXHIBIT 4.4 exhibit4-4.htm EX-4.4 85474
4 EXHIBIT 8.1 exhibit8-1.htm EX-8.1 1807
5 EXHIBIT 12.1 exhibit12-1.htm EX-12.1 12488
6 EXHIBIT 12.2 exhibit12-2.htm EX-12.2 12310
7 EXHIBIT 13.1 exhibit13-1.htm EX-13.1 5530
8 EXHIBIT 15.5 exhibit15-5.htm EX-15.5 19044
9 EXHIBIT 15.6 exhibit15-6.htm EX-15.6 16648
15 GRAPHIC exhibit15-5x001.jpg GRAPHIC 10256
16 GRAPHIC exhibit15-6x001.jpg GRAPHIC 10256
17 GRAPHIC form20fxz001.jpg GRAPHIC 52493
18 GRAPHIC form20fxz002.jpg GRAPHIC 58537
19 GRAPHIC form20fxz003.jpg GRAPHIC 19499
20 GRAPHIC form20fxz004.jpg GRAPHIC 14463
  Complete submission text file 0001062993-24-021301.txt   8328391

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT drug-20240930.xsd EX-101.SCH 123212
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT drug-20240930_cal.xml EX-101.CAL 34188
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT drug-20240930_def.xml EX-101.DEF 264927
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT drug-20240930_lab.xml EX-101.LAB 1061471
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT drug-20240930_pre.xml EX-101.PRE 395718
83 EXTRACTED XBRL INSTANCE DOCUMENT form20f_htm.xml XML 1041028
Mailing Address 19 VESTRY STREET NEW YORK NY 10013
Business Address 19 VESTRY STREET NEW YORK NY 10013 6474072515
BRIGHT MINDS BIOSCIENCES INC. (Filer) CIK: 0001827401 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 20-F | Act: 34 | File No.: 001-40997 | Film No.: 241590899
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)